UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000017902
Receipt number R000020386
Scientific Title Phase I clinical trial of preoperative arterial immuno-embolization with OK-432 / fibrinogen / lipiodol for resectable primary hepatocellular carcinoma
Date of disclosure of the study information 2015/06/15
Last modified on 2019/11/06 18:46:50

No. Disposal Last modified on Item of update
1 Insert 2015/06/14 18:39:13
2 Update 2016/06/14 13:57:27 Name of primary person or sponsor
Organization
Organization
3 Update 2016/12/19 11:24:30 Interventions/Control_1
4 Update 2017/06/14 15:24:13 Last name of lead principal investigator
Last name of lead principal investigator
Division name
Division name
TEL
Division name
Division name
TEL
Division name
Division name
TEL
Institute
Institute
Co-sponsor
Co-sponsor
5 Update 2017/06/14 15:25:41 Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
6 Update 2019/06/17 09:19:49 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code

Last name of contact person

Last name of contact person
Zip code
Email3
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/06/17 09:25:08 Date of IRB
8 Update 2019/06/17 09:25:50 Recruitment status
9 Update 2019/11/06 18:46:50 URL releasing protocol
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures